Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Sensitivity and specificity of antibodies against HPV16 E6 and other early proteins for the detection of HPV16‐driven oropharyngeal squamous cell carcinoma
Dana Holzinger, Gunnar Wichmann, Lorena Baboçi, et al.
International Journal of Cancer (2017) Vol. 140, Iss. 12, pp. 2748-2757
Open Access | Times Cited: 108

Showing 1-25 of 108 citing articles:

The molecular landscape of head and neck cancer
C. René Leemans, Peter J.F. Snijders, Ruud H. Brakenhoff
Nature reviews. Cancer (2018) Vol. 18, Iss. 5, pp. 269-282
Closed Access | Times Cited: 1122
A Review of HPV-Related Head and Neck Cancer
Kazuhiro Kobayashi, Kenji Hisamatsu, Natsuko Suzui, et al.
Journal of Clinical Medicine (2018) Vol. 7, Iss. 9, pp. 241-241
Open Access | Times Cited: 261
Head and neck cancer prevention: from primary prevention to impact of clinicians on reducing burden
Dana Hashim, Eric M. Genden, Marshall R. Posner, et al.
Annals of Oncology (2019) Vol. 30, Iss. 5, pp. 744-756
Open Access | Times Cited: 217
Novel prognostic clinical factors and biomarkers for outcome prediction in head and neck cancer: a systematic review
Volker Budach, Ingeborg Tinhofer
The Lancet Oncology (2019) Vol. 20, Iss. 6, pp. e313-e326
Closed Access | Times Cited: 150
Trends in Human Papillomavirus–Associated Cancers, Demographic Characteristics, and Vaccinations in the US, 2001-2017
Cheng-I Liao, Alex Francoeur, Daniel S. Kapp, et al.
JAMA Network Open (2022) Vol. 5, Iss. 3, pp. e222530-e222530
Open Access | Times Cited: 110
Epidemiology of HPV-associated cancers past, present and future: towards prevention and elimination
Talía Malagón, Eduardo L. Franco, Romina A. Tejada, et al.
Nature Reviews Clinical Oncology (2024) Vol. 21, Iss. 7, pp. 522-538
Closed Access | Times Cited: 35
Serum, plasma and saliva biomarkers for head and neck cancer
Lídia Maria Rebolho Batista Arantes, Ana Carolina de Carvalho, Matias Eliseo Melendez, et al.
Expert Review of Molecular Diagnostics (2017) Vol. 18, Iss. 1, pp. 85-112
Closed Access | Times Cited: 144
Understanding personal risk of oropharyngeal cancer: risk-groups for oncogenic oral HPV infection and oropharyngeal cancer
G. D’Souza, Tim S. McNeel, Carole Fakhry
Annals of Oncology (2017) Vol. 28, Iss. 12, pp. 3065-3069
Open Access | Times Cited: 111
Disease burden, risk factors, and trends of lip, oral cavity, pharyngeal cancers: A global analysis
Junjie Huang, Sze Chai Chan, Samantha Ko, et al.
Cancer Medicine (2023) Vol. 12, Iss. 17, pp. 18153-18164
Open Access | Times Cited: 27
Current and Emerging Diagnostic, Prognostic, and Predictive Biomarkers in Head and Neck Cancer
Hänel W. Eberly, Bao Y. Sciscent, F. Jeffrey Lorenz, et al.
Biomedicines (2024) Vol. 12, Iss. 2, pp. 415-415
Open Access | Times Cited: 12
Timing of HPV16-E6 antibody seroconversion before OPSCC: findings from the HPVC3 consortium
A.R. Kreimer, Aida Ferreiro-Iglesias, Mari Nygård, et al.
Annals of Oncology (2019) Vol. 30, Iss. 8, pp. 1335-1343
Open Access | Times Cited: 74
Human papillomavirus 16 E6 antibodies are sensitive for human papillomavirus–driven oropharyngeal cancer and are associated with recurrence
Krystle A. Lang Kuhs, Aimée R. Kreimer, Sumita Trivedi, et al.
Cancer (2017) Vol. 123, Iss. 22, pp. 4382-4390
Open Access | Times Cited: 73
HPV Detection in Head and Neck Squamous Cell Carcinomas: What Is the Issue?
Jérémy Augustin, Charles Lépine, Aurélien Morini, et al.
Frontiers in Oncology (2020) Vol. 10
Open Access | Times Cited: 67
Screening for human papillomavirus‐driven oropharyngeal cancer: Considerations for feasibility and strategies for research
Aimée R. Kreimer, Meredith S. Shiels, Carole Fakhry, et al.
Cancer (2018) Vol. 124, Iss. 9, pp. 1859-1866
Open Access | Times Cited: 63
Timing, number, and type of sexual partners associated with risk of oropharyngeal cancer
Virginia E. Drake, Carole Fakhry, Melina J. Windon, et al.
Cancer (2021) Vol. 127, Iss. 7, pp. 1029-1038
Open Access | Times Cited: 56
Long-term Persistence of Oral HPV Over 7 Years of Follow-up
Gypsyamber D’Souza, Gwendolyn Clemens, Howard D. Strickler, et al.
JNCI Cancer Spectrum (2020) Vol. 4, Iss. 5
Open Access | Times Cited: 51
Sensitivity and Specificity of Human Papillomavirus (HPV) 16 Early Antigen Serology for HPV-Driven Oropharyngeal Cancer: A Systematic Literature Review and Meta-Analysis
Julia Hibbert, Gordana Halec, Dan Baaken, et al.
Cancers (2021) Vol. 13, Iss. 12, pp. 3010-3010
Open Access | Times Cited: 44
HPV and head and neck cancers: Towards early diagnosis and prevention
Luisa Galati, Susanna Chiocca, Daria Duca, et al.
Tumour Virus Research (2022) Vol. 14, pp. 200245-200245
Open Access | Times Cited: 38
Prevention and treatment of human papillomavirus in men benefits both men and women
Kangni Zou, Yue Huang, Zhengyu Li
Frontiers in Cellular and Infection Microbiology (2022) Vol. 12
Open Access | Times Cited: 36
Absolute Risk of Oropharyngeal Cancer After an HPV16-E6 Serology Test and Potential Implications for Screening: Results From the Human Papillomavirus Cancer Cohort Consortium
Hilary A. Robbins, Aida Ferreiro-Iglesias, Tim Waterboer, et al.
Journal of Clinical Oncology (2022) Vol. 40, Iss. 31, pp. 3613-3622
Open Access | Times Cited: 34
Performance of oral HPV DNA, oral HPV mRNA and circulating tumor HPV DNA in the detection of HPV‐related oropharyngeal cancer and cancer of unknown primary
Hidenori Tanaka, Motoyuki Suzuki, Norihiko Takemoto, et al.
International Journal of Cancer (2021) Vol. 150, Iss. 1, pp. 174-186
Open Access | Times Cited: 40
Germline determinants of humoral immune response to HPV-16 protect against oropharyngeal cancer
Aida Ferreiro-Iglesias, James McKay, Nicole Brenner, et al.
Nature Communications (2021) Vol. 12, Iss. 1
Open Access | Times Cited: 37
Liquid Biopsies with Circulating Plasma HPV–DNA Measurements—A Clinically Applicable Surveillance Tool for Patients with HPV-Positive Oropharyngeal Cancer
Kathrine Kronberg Jakobsen, Simone K. Bendtsen, Niels Pallisgaard, et al.
Clinical Cancer Research (2023) Vol. 29, Iss. 19, pp. 3914-3923
Closed Access | Times Cited: 16
Evaluating the Utility and Prevalence of HPV Biomarkers in Oral Rinses and Serology for HPV-related Oropharyngeal Cancer
Gypsyamber D’Souza, Gwendolyn Clemens, Tanya Troy, et al.
Cancer Prevention Research (2019) Vol. 12, Iss. 10, pp. 689-700
Open Access | Times Cited: 43
A Literature Review of the Potential Diagnostic Biomarkers of Head and Neck Neoplasms
Heleen Konings, Sofie Stappers, Margot Geens, et al.
Frontiers in Oncology (2020) Vol. 10
Open Access | Times Cited: 39
Page 1 - Next Page

Scroll to top